FundedIQ
Biotechnology

Novir: Funding, Investors & Team (Oct 2026)

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.

novir-usa.com LinkedIn Milwaukee, United States 51-100 employees Founded 2020
Total raised
$3.1M
Rounds
1
Latest
Seed
Aug 2026

Novir has raised $3.1M across 1 funding round on record, the most recent a Seed of $3.1M announced in Aug 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Novir Company Profile and Key Stats

Total funding raised
$3.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$3.1M in Aug 2026
Employees
51-100
reported band
Founded
2020
Headquarters
Milwaukee, United States

Latest funding round on record: Aug 2026.

Novir Funding Rounds

Date
Round
Amount
Seed
$3.1M

Novir Founders and Leadership Team

Name
Role
Contact
Alexander Orozco
CEO and Founder
Locked
Andreas Klotz
Vice President, Remote Health Solutions
Locked

Contact details for the Novir team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Novir Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Novir's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Novir in Biotechnology and Milwaukee

Companies Similar to Novir

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Novir Funding FAQs

What does Novir do?

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.

How much funding has Novir raised?

Novir has raised $3.1M across 1 round on record. The most recent is a Seed of $3.1M announced in Aug 2026.

When did Novir last raise funding?

Novir's most recent funding round on record is a Seed of $3.1M, announced in Aug 2026.

Who founded Novir?

FundedIQ lists Alexander Orozco (CEO and Founder) at Novir.

Where is Novir headquartered?

Novir is based in Milwaukee, United States.

How many employees does Novir have?

Novir is in the 51-100 employee band.

When was Novir founded?

Novir was founded in 2020.

How does Novir's funding compare to other Biotechnology startups?

Novir's latest round of $3.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Novir Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Novir is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.